| 1. |
Robertson DM. Non-cancerous ophthalmic clues to non-ocular cancer[J]. Surv Ophthalmol, 2002, 47:397-430.
|
| 2. |
Savchenko MS, Goncharskaia MA, Skorikova EE, et al. Autoantibodies against the Ca2+-binding protein recoverin in blood sera of patients with various oncological diseases[J]. Oncol Lett,2012,3:377-382.
|
| 3. |
Khan N, Huang JJ, Foster CS. Cancer associated retinopathy (CAR):an autoimmune-mediated paraneoplastic syndrome[J]. Semin Ophthalmol, 2006,21:135-141.
|
| 4. |
Ling CP, Pavesio C. Paraneoplastic syndromes associated with visual loss[J]. Curr Opin Ophthalmol,2003,14:426-432.
|
| 5. |
Anastasakis A, Dick AD, Damato EM, et al. Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction[J]. Doc Ophthalmol,2011,123:59-63.
|
| 6. |
Cheour M, Agrebi S, Hijazi A. Cancer associated retinopathy with periphlebitis and bilateral vitr eous hemorrhage[J]. Bull Soc Belge Ophtalmol,2013,322:71-76.
|
| 7. |
Abazari A, Allam SS, Adamus G, et al. Optical coherence tomography findings in autoimmune retinopathy[J]. Am J Ophthalmol,2012,153:750-756.
|
| 8. |
Sampedro A, Carballo C, Barbon JJ, et al. Ocular paraneoplastic syndrome:cancer-associated retinopathy[J]. Arch Soc Esp Oftalmol,2013,88:407-409.
|
| 9. |
Sakamori Y, Kim YH, Okuda C, et al. Two cases of cancer-associated retinopathy combined with small-cell lung cancer[J]. Jpn J Clin Oncol,2011,41:669-673.
|
| 10. |
陈菲,姜利斌,闫伟玉,等.误诊为视神经疾病的急性区域性隐匿性外层视网膜病变患者的临床分析[J]. 中华眼科杂志,2013,49:495-499.
|
| 11. |
Huynh N, Shildkrot Y, Lobo AM, et al. Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy[J]. J Ophthalmic Inflamm Infect,2012,2:169-171.
|
| 12. |
Ferreyra HA, Jayasundera T, Khan NW, et al. Management of autoimmune retinopathies with immunosuppression[J]. Arch Ophthalmol,2009,127:390-397.
|
| 13. |
Or C, Collins DR, Merkur AB, et al. Intravenous rituximab for the treatment of cancer-associated retinopathy[J]. Can J Ophthalmol,2013,48:35-38.
|
